Portal de Periódicos da CAPES

Clonidine*: Quo vadis?

1985; Wiley; Volume: 142; Issue: 4 Linguagem: Italiano

10.5694/j.1326-5377.1985.tb113324.x

1326-5377

Derek B. Frewin,

Health Systems, Economic Evaluations, Quality of Life

Medical Journal of AustraliaVolume 142, Issue 4 p. 254-256 Therapeutics Clonidine*: Quo vadis? Derek B. Frewin MD, FRACP, Derek B. Frewin MD, FRACP Reader Department of Clinical and Experimental Pharmacology, The University of Adelaide, Box 498 GPO, Adelaide, SA, 5001 Clinical PharmacologySearch for more papers by this author Derek B. Frewin MD, FRACP, Derek B. Frewin MD, FRACP Reader Department of Clinical and Experimental Pharmacology, The University of Adelaide, Box 498 GPO, Adelaide, SA, 5001 Clinical PharmacologySearch for more papers by this author First published: 01 February 1985 https://doi.org/10.5694/j.1326-5377.1985.tb113324.xCitations: 2 *Sixth article in an occasional series on therapy in cardiovascular disease. ‡Reprints: Dr D.B. Frewin. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume142, Issue4February 1985Pages 254-256 RelatedInformation